Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials

Objective. Data from randomized clinical trials with metabolic outcomes can be used to address concerns about potential issues of cardiovascular safety for newer drugs for type 2 diabetes. This meta-analysis was designed to assess cardiovascular safety of GLP-1 receptor agonists. Design and Methods....

Full description

Saved in:
Bibliographic Details
Main Authors: Monami, Matteo, Cremasco, Francesco, Lamanna, Caterina, Colombi, Claudia, Desideri, Carla Maria, Iacomelli, Iacopo, Marchionni, Niccolò, Mannucci, Edoardo
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2011
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3092497/
https://ncbi.nlm.nih.gov/pubmed/21584276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/215764
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items